| Identification | Back Directory | [Name]
EBE-A 22 | [CAS]
229476-53-3 | [Synonyms]
EBE-A 22
EBE-A22, >98%
PD153035 Analog 63
N-(3-Bromophenyl)-6,7-dimethoxy-N-methyl-4-quinazolinamine
N-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine
4-Quinazolinamine, N-(3-bromophenyl)-6,7-dimethoxy-N-methyl- | [Molecular Formula]
C17H16BrN3O2 | [MDL Number]
MFCD18782710 | [MOL File]
229476-53-3.mol | [Molecular Weight]
374.23 |
| Chemical Properties | Back Directory | [Boiling point ]
507.3±50.0 °C(Predicted) | [density ]
1.446±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 50 mg/mL (133.61 mM); Water: < 0.1 mg/mL (insoluble) | [form ]
Solid | [pka]
5.65±0.30(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
EBE-A 22 is an epidermal growth factor receptor inhibitor EGFR, an important target for the treatment of cancer. Selective VEGFR-2 receptor tyrosine kinase inhibitors. | [storage]
Store at -20°C |
|
|